Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article

 

Takeda Pharmaceuticals President Quits

Merck & Co., NewLink Genetics In Secret Talks On Producing Ebola Vaccine

AstraZeneca PLC Will Invest $200M, Add 300 Jobs In Maryland Plant Expansion

Pennsylvania Bio CEO: Move A Wake-Up Call

Ebola Vaccine Running Into Patent Cover In Canada?

Hand Dryers Can Spread Bacteria In Public Toilets, University of Leeds Research Finds

Lincoln Park Doubles Down On Oncology With $55M Galena Biopharma Bet

Genzyme Corporation Parent Running At ???Full Speed,??? Chairman Says

France Strikes Deal For Gilead Sciences, Inc.'s Hep C Drug Sovaldi

For Women, Job Authority Adds To Depression Symptoms, University of Texas Study

Many People Who Drink A Lot Aren't Alcoholics:

AbbVie Nabs Positive Opinions For VIEKIRAX Plus EXVIERA To Treat HCV

Purdue Pharma L.P. Wins FDA Approval For Powerful Painkiller Hysingla

Dominant People Can Be Surprisingly Social, Study

Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million

Genzyme Europe BV Cerdelga Gets EU Recommended For Approval In Type 1 Gaucher Disease

So What About That Acrylamide In Your French Fries?

Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine)

Pac-Man Instead of Patch: Using Video Games To Improve Lazy Eye, Depth Perception, Ohio State University Study

European Medicines Agency Recommends Availability Of s Ellaone Emergency Contraceptive Without Prescription

Training Can Lead To Synaesthetic Experiences, Study Shows

AbbVie Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia

Ohio State University Scientists Study Effects Of Sunlight To Reduce Number Of Nearsighted Kids

Celgene Receives Positive Opinion For OTEZLA (apremilast), The First Oral PDE4 Inhibitor For The Treatment Of Patients With Psoriasis And Psoriatic Arthritis

EXCLUSIVE: Says ???Biggest Mistake??? In Allergan Bid Was Tender Offer

Altasciences Further Expands Its Footprint With Algorithme Pharma USA

Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup

Drug Trial Results Can't Be Hidden Under Proposed Rules

Shire To Relocate Over 500 Jobs To New Massachusetts Headquarters

Top 10 Countries For Diabetes Clinical Research

Regeneron, ReGen Therapeutics Plc Eczema Drug Dupilumab Gets Sanofi Breakthrough Therapy Designation

Sanofi Aims To Launch 18 New Drugs By 2020

Case Western Reserve University Researchers Characterize A Protein Mutation That Alters Tissue Development In Males Before Birth

Fred Hutchinson Cancer Research Center Recruits As Its New President And Director

Neothetics Prices IPO

BioNano Genomics Raises $53 Million Series C

Rockwell Medical Prices $58.5 Million Public Offering Of Common Stock

Cowen: Acorda Therapeutics Not Worried About Civitas Therapeutics' New Parkinson's Drug

Ironwood Pharmaceuticals Earns $15 Million Milestone From Astellas Pharma Inc.

Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. To Manufacture Its Lead Anti-Cancer Compound, Adva-27a

Northwest Biotherapeutics Reports $35M In Financing

Sanofi Creates Candidate Shortlist For Top CEO Job: Report

Amgen Opens New Biomanufacturing Facility In Singapore

U.S. FDA Grants Fast Track Designation To Novavax, Inc.' RSV F-Protein Nanoparticle Vaccine For Protection Of Infants Via Maternal Immunization

Bausch & Lomb Creates 50 New Jobs In Waterford

Knight Therapeutics Sells Priority Review Voucher To Gilead Sciences, Inc. For US$125 Million Cash

Apellis Pharmaceuticals To Acquire Potentia Pharmaceuticals, Inc.

The Growing Presence Of Biotech In The World Of Social Media

Synchrogenix Appoints New CEO Kelley Kendle

A New Test Measures Analytical Thinking Linked To Depression, Fueling The Idea That Depression May Be A Form Of Adaptation, McMaster University Study

Solid Lymphoma Data Points To Larger Potential For Epizyme, Says Citi

Sanofi And Regeneron's Alirocumab Ph3 Trials Met Primary Efficacy Endpoint

High Heels May Enhance A Man???s Instinct To Be Helpful, Study

Low Vitamin D Levels Increase Mortality, University of Copenhagen Study

National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG's Xolair To Treat Chronic Hives

U.S. Court Overturns Bid By India's Ranbaxy Laboratories To Block Launch Of Rival Generic Drugs

University of California, Los Angeles (UCLA) Stem Cell Researcher Pioneers Gene Therapy Cure For Children With ???Bubble Baby??? Disease

PharmaEngine Announces The Receipt Of US FDA Fast Track Designation For MM-398 In Post-Gemcitabine Metastatic Pancreatic Cancer By Merrimack Pharmaceuticals Inc.

Complex Jobs "May Protect Memory," Study

Spice Up Your Memory, Monash University Study

Abbott Vascular Cuts 100 Jobs At California Plant

Does "Brain Training" Work? University of Sydney Study

Alcoholism Damages Brain's White Matter, Scans Show, Harvard Medical School And Study

Oxford Pharmaceuticals Plans New U.S. Location With 200 Jobs

Taking Antibiotics During Pregnancy Increases Risk For Child Becoming Obese, Columbia University Study

Most People Would Rather Harm Themselves Than Others For Profit, University College London Study

Royalty Pharma Buys Royalties On Vertex Pharmaceuticals Incorporated Drugs For $3.3 Billion

LEO Pharma Appoints As President & CEO Of U.S. Region

Merrimack Pharmaceuticals Inc. Receives FDA Fast Track Designation For MM-398 In Post-Gemcitabine Metastatic Pancreatic Cancer

Ackman's Pershing Square Withdraws Call For Allergan Inc. Special Shareholder Meeting

Esperion Therapeutics, Inc. Climbs As CEO Lauds Merck & Co.'s Zetia Data

Charity Alliance To Sink ??30m Into Brain Disease Research

Layoff Plans Changed; 199 Ricerca Biosciences CRO Jobs Saved

Verdezyne, Inc. To Build And Operate World???s First Bio-Based Dodecanedioic Acid (DDDA) Plant In Malaysia; 3,000 New Jobs Expected

N30 Pharma Secures $30 Million In Oversubscribed Crossover Financing

MSF Scorns Tufts Center (An Affiliate of Tufts University) Study On Cost To Develop Drugs

Average Drug Costs $2.6 Billion To Develop; Critics Wary

Mela Sciences Names Its Next President And CEO

NeoStem, Inc.'s Stem Cell Therapy Fails Mid-Stage Heart Attack Study

FDA Puts Partial Hold On CytRx Corporation's Aldoxorubicin Clinical Trials

Cynapsus Therapeutics Announces Positive Top-Line Results From CTH-105 Phase 2 Study Of APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease

LentiGlobin Looks Promising On Sickle Cell For bluebird bio, Says Analyst

Merck & Co.'s Vytorin Proves Effective; IMPROVE-IT Trial Achieves Primary Endpoint

The Dirty Side Of Soap, University of California, San Diego (UCSD) Study

Cancer Biotech Bellicum Pharmaceuticals, Inc. Files For $115 Million IPO

Trans Fat Consumption Is Linked To Diminished Memory In Working-Aged Adults, University of California, San Diego (UCSD) Study

Could Wine, Chocolate Protect The Heart From Smog? Harvard School of Public Health Study

Data Carries More Weight With Science Adherents, Cornell University Study Finds

Job Cuts Hit Health Diagnostic Laboratory Inc.

Women's Fertility Linked To Detox Element In Diet, University of Adelaide Study

NorthShore University HealthSystem Research Institute Study Suggests Genetic Link For Male Homosexuality

Surprise! Vytorin Works. Here Are Five Things You Should Know.

Working The Night Shift Burns Less Energy And Increases Risk Of Weight Gain, University of Colorado Study

Clovis Oncology Rises On News Of GlaxoSmithKline Oncology Collaboration

Large Japanese Trial Casts Further Doubt On Aspirin To Prevent A First Heart Attack, JAMA Reveals

AstraZeneca PLC Shows Off Strong Drug Pipeline As Pfizer Deadline Looms

Forward Pharma Sues Biogen Idec Over Tecfidera Sales In Germany

Regeneron's Eylea Gets Japanese Nod For Macular Edema

Newly Formed Announces $15 Million In Funding

Renova Therapeutics Welcomes New Board Member, Raises $7.52 Million In Series C Financing Round

Actavis Agrees To Buy Allergan Inc. For $66 Billion

Takeda Pharmaceutical Co. Ltd. Ordered To Pay $155,000 For Destroyng Files

Gilead Sciences, Inc. Stock Rises After European Commission (EC) Market Authorization For Harvoni

Ranbaxy Laboratories Sues FDA Over Revoking Approvals For Nexium, Valcyte Copies

Pfizer, Merck KGaA Strike A $2.9B Deal To Develop Cancer Tumor Treatment

Are We Visual Or Auditory Or Kinesthetic Learners? Three Myths Of Neuroscience Exploded

Chemical In Coffee May Help Prevent Obesity-Related Disease, University of Georgia Study

Paulson Opens New Stake In AbbVie, Nearly Triples Shire Shares

Walnuts Slow Prostate Cancer In Mice, University of California, Davis (UCD) Study

University of North Carolina Researchers Silence Leading Cancer-Causing Gene

Rice University Study: Disgust Leads People To Lie And Cheat; Cleanliness Promotes Ethical Behavior

Best Value In Biotech? Actavis, Says UBS

Juno Therapeutics Files For IPO

Reckitt Benckiser Plc Launches Pharma Spin-Off

FDA Approves Genzyme Corporation???s Lemtrada For MS

Inovio Pharmaceuticals, Roche Terminated Collaboration To Co-develop INO-5150

ISI: Merck & Co.???s Zetia News The Rising Tide To Lift All LDL Boats

Valeant Buys In $20 Million Deal

Baring Asia Says Agrees To Buy Japan Drugmaker Bushu From Tokio Marine

Tekmira Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals

Sun Pharmaceutical Industries Ltd Recalls 68,194 Bottles Of Anti-Depression Drug In U.S.

DiaMedica Inc. Announces Top-Line Results Of Phase 2a Clinical Trial Of DM199 For Type 2 Diabetes

ZS Pharma Presents Positive Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia, At The American Heart Association Scientific Meeting And Announces Simultaneous Publication Of Results In JAMA

Zoetis To Purchase Assets Of Abbott Animal Health

If Investors Like Merck & Co.'s Zetia Results, They Will Love Esperion Therapeutics, Inc.???s, Says Citi

222


    Read more..